Future of Pharma Marketing | Day 2:

Gain insight into today’s sessions so you can get the most out of your conference experience.

As pharma accelerates investment in AI and personalized engagement, the challenge is no longer understanding potential but applying innovations successfully. Explore how the regulatory frameworks are evolving so that you can apply them in real-world applications. Take away key insights to:   

• Adapt and move beyond AI theory to understand how automated and assistant content review is being applied to real-world reviews of promotional and commercial material.   
• Reduce the tension between speed and rigor by navigating integration of preclearance requirements. 
• Transform evolving grey areas in data use and personalized engagement to minimize regulatory risk. 
• Perfect industry-regulator collaboration to build transparent frameworks that enable rapid innovation.   
• Amplify the growing role of Real-World Evidence (RWE) in shaping compliant, credible communications.  

Apply AI and real-world evidence confidently within evolving regulatory frameworks to accelerate innovation while minimizing compliance risk.

Pharma is moving from monolithic PDFs to “Lego-brick” content. This shift enables you to engage in high-speed assembly for 2026’s hyper-personalized HCP journeys. Source practical tips to: 

• Transform and move beyond static PDFs to understand how pre-approved content blocks are being applied. 
• Heighten the foundational role of metadata and tagging in shaping a searchable, AI-ready library of assets. 
• Reduce the ongoing tension between creative flexibility and regulatory rigor. 
• Master the evolving technical and process silos to align global content strategy with local market execution. 

 Optimize how modular architecture enables AI to act as a conductor, without compromising compliance.

As AI adoption accelerates across pharmaceutical sales and marketing functions, organizations must balance innovation with compliance. Adapt your approach to ensure success. Take away a blueprint for: 

• Transforming complex regulatory landscape from data privacy regulations and promotional review processes to AI governance frameworks and risk management.  
• Mastering AI-driven technologies while maintaining compliance, protecting patient and HCP data, and building trust.  
• Optimizing responsible innovation in the AI. 

 Perfect ethical AI practices, transparency, and accountability into pharma commercial strategies.

Take a deep dive down the innovation rabbit hole in one of our focused roundtable discussions. Share common challenges and best practices with your pharma marketing and sales peers on a topic of your choosing. 

1. AI and automation in pharma commercial teams. 
2. Patient-centric engagement and adherence strategies. 
3. Omnichannel execution challenges and success factors. 
4. Specialty and rare disease commercialisation. 
5. Sales rep evolution and hybrid engagement models. 
6. Cross-functional collaboration between sales, marketing, and medical. 
7. Turning data into commercial action: from insight to impact. 
8. Delivering personalized customer experiences at scale. 

While many pharma organizations have embraced omnichannel strategies, few have successfully scaled them across brands, regions, and teams. Close the gap between your strategy and execution. Adopt best practices to: 

• Transition from pilot programs to enterprise-wide omnichannel execution. 
• Perfect customer journeys that integrate field, digital, and hybrid touchpoints. 
• Optimize channels in real time: data, content, and timing. 
• Amplify sales and marketing teams with the right tools and insights.  
• Heighten content modularization and reuse for scale and speed.

Ensure compliance while maintaining your agility.

As customer expectations continue to be shaped by consumer industries, pharma organizations need to adapt. Translate consumer health and your cross-industry strategies into practical, compliant, and scalable commercial models. Take away insights to: 

• Impact what pharma can realistically adopt from consumer health and other industries. 
• Optimize moving from channel-led to experience-led engagement strategies. 
• Master delivering personalization at scale within regulatory constraints. 
• Amplify trust through transparency, relevance, and value-driven interactions. 
• Increase lessons learned from implementing new engagement models. 

 Deliver scalable, personalized, and compliant engagement strategies that enhance trust and shift pharma marketing toward experience-led customer interactions. 

As customer expectations continue to evolve, pharma organizations are under pressure to deliver across every interaction. Leverage your data, AI, and omnichannel orchestration. Source your plan of action by: 

• Transforming customer engagement in a hyper-digital, insight-driven world.
• Excelling the use of AI and predictive analytics to anticipate customer needs.
• Perfecting real-time engagement across field, digital, and remote channels.
• Increasing building scalable content strategies that support personalization.

Balance your personalization with privacy, compliance, and trust.

• Browse through different sponsor booths and test drive new technology. 
• Enter your name for a chance to win exciting prizes.   
• Take advantage of event-specific offers and special content. 

• Enjoy exclusive sponsor demos and experience the next level of pharma marketing and sales innovation firsthand.
• Meet one-on-one with leading solution providers to discuss organizational hurdles.
• Brainstorm solutions and gain new perspectives and ideas.

As pharma organizations expand their digital and omnichannel capabilities, marketing technology stacks have become increasingly complex. Bolster how you rationalize, govern, and scale your MarTech ecosystems. Take back to your office strategies to: 

• Achieve a future-ready MarTech architecture: principles and priorities.  
• Impact tool sprawl: assessing, consolidating, and optimizing platforms.  
• Reduce integration challenges: connecting CRM, CDP, marketing automation, and analytics systems.  
• Optimize and establish governance models for cross-functional alignment and accountability. 

Balance global standardization with your local market flexibility.

As many pharma brands move beyond their peak growth phase, the challenge shifts from launch to sustaining and reinvigorating performance. Successfully transform your mature brand into renewed growth drivers. Take away solutions to: 

• Achieve new growth opportunities within established brands and portfolios. 
• Master how you use data and insights to uncover untapped segments. 
• Align brands through targeted messaging and omnichannel engagement. 
• Enhance commercial, medical, and market access strategies for lifecycle success. 

Increase brand value through innovation, partnerships, and new delivery models.

Review the key solutions and takeaways from the conference. Source a summary of action points to implement in your work.